In vitro oxime reactivation of red blood cell acetylcholinesterase inhibited by methyl-paraoxon

Journal of Applied Toxicology

Volumn 27, Issue 2, 2007, Pages 168-175

  Petroianu, Georg A ^a   Arafat, K ^a   Nurulain, S M ^a   Kuca K ^b   Kassa, J ^b  

^a UNITED ARAB EMIRATES UNIVERSITY   (United Arab Emirates)

^b UNIVERSITY OF DEFENCE   (Czech Republic)

Author keywords

Cholinesterase; K oxime; Methoxime; Methyl paraoxon; Organophosphate; Oxime; Pralidoxime

Indexed keywords

1 (4 HYDROXYIMINOMETHYLPYRIDIUM) 3 (4 CARBAMOYLPYRIDIUM)PROPANE DIBROMIDE; 1 (4 HYDROXYIMINOMETHYLPYRIDIUM) 4 (4 CARBAMOYLPYRIDIUM)BUTANE DIBROMIDE; 1,4 BIS(2 HYDROXYIMINOMETHYLPYRIDIUM)BUTANE DIBROMIDE; ACETYLCHOLINESTERASE; K 27; K 33; K 48; METHOXIME; METHYLPARAOXON; OXIME DERIVATIVE; PARAOXON; PRALIDOXIME; UNCLASSIFIED DRUG;

ARTICLE; CELL PROTECTION; CONTROLLED STUDY; DOSE CALCULATION; DOSE RESPONSE; DRUG BINDING; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME REACTIVATION; ERYTHROCYTE; HUMAN; HUMAN CELL; IC 50; IN VITRO STUDY; LINEAR SYSTEM; PHOTOMETRY; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS;

CHOLINESTERASE INHIBITORS; CHOLINESTERASE REACTIVATORS; DRUG ANTAGONISM; ERYTHROCYTES; FEMALE; HUMANS; INHIBITORY CONCENTRATION 50; MALE; OXIMES; PARAOXON; PRALIDOXIME COMPOUNDS; PYRIDINIUM COMPOUNDS; QUANTITATIVE STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 33947611114     PISSN: 0260437X     EISSN: 10991263     Source Type: Journal    
DOI: 10.1002/jat.1189     Document Type: Article

References (26)

1. Alston TA. 2005. Pralidoxime rescues both muscarinic and nicotinic systems. Anesth. Analg. 101: 926-927.
2. Arunlakshana O, Schild HO. 1959. Some quantitative uses of drug antagonists. Br. J. Pharmacol. 14: 48-58.
3. Bajgar J. 2004. Organophosphates/nerve agent poisoning: mechanism of action, diagnosis, prophylaxis, and treatment. Adv. Clin. Chem. 38: 151-216.
4. Buckley N, Eddleston M, Szinicz L. 2005. Oximes for acute organophosphate pesticide poisoning. Cochrane Database Syst Rev. 1: CD005085.
5. 50. A closer look at the Cheng-Prusoff equation, the Schild plot and related power equations. J. Pharmacol. Toxicol. Methods 46: 61-71.
6. Eddleston M, Szinicz L, Eyer P, Buckley N. 2002. Oximes in acute organophosphorus pesticide poisoning: a systematic review of clinical trials. Q J Med. 95: 275-283.
7. Ellman GL, Courtney KD, Feather-Stone RM, Andres V Jr. 1961. A new and rapid colorimetric determination of acetyl-cholinesterase activity. Biochem. Pharmacol. 7: 88-95.
8. Hobbiger F, Sadler PW. 1959. Protection against lethal organophosphate poisoning by quaternary pyridine aldoximes. Br. J. Pharmacol. 14: 192-201.
9. Johnson MK, Jacobsen D, Meredith TJ, Eyer P, Heath AJ, Ligtenstein DA, Marrs TC, Szinicz L, Vale JA, Haines JA. 2000. Evaluation of antidotes for poisoning by organophosphorus pesticides. Emerg. Med. 12: 22-37.
10. Kassa J. 2002. Review of oximes in the antidotal treatment of poisoning by organophosphorus nerve agents. J. Toxicol. Clin. Toxicol. 6: 803-816.
11. Kuča K, Bielavský J, Cabal J, Bielavska M. 2003a. Synthesis of a potential reactivator of acetylcholinesterase - 1-(4- hydroxyiminomethylpyridinium)-3-(carbamoylpyridiniurn)-propane dibromide. Tetrahedron Lett. 44: 3123-3125.
12. Kuča K, Bielavský J, Cabal J, Kassa J. 2003b. Synthesis of a new reactivator of tabun-inhibited acetylcholinesterase. Bioorg. Med. Chem. Lett. 13: 3545-3547.
13. Kuča K, Cabal J, Patočka J, Kassa J. 2004. Synthesis of bisquaternary symmetric bis (2-hydroxyiminomethylpyridinium) alkane dibromides and their reactivation of cyclosarin-inhibited acetylcholinesterase. Lett. Org. Chem. 1: 84-86.
14. Namba T. 1971. Cholinesterase inhibition by organophosphorus compounds, and its clinical effects. Bull WHO 44: 289-307.
15. Namba T, Nolte CT, Jackrel J, Grob D. 1971. Poisoning due to organophosphate insecticides: acute and chronic manifestations. Am. J. Med. 50: 457-492.
16. Peter JV, Cherian AM. 2000. Organic insecticides. Anaesth. Intensive Care 28: 11-21.
17. Peter JV, Moran JL, Graham P. 2006. Oxime therapy and outcomes in human organophosphate poisoning: an evaluation using meta-analytic techniques. Crit. Care Med. 34: 502-510.
18. Petroianu GA. 2005. Pralidoxime rescues both muscarinic and nicotinic systems: In response. (letter) Anesth. Analg. 101: 926-927.
19. Petroianu GA, Arafat K, Kuča K, Kassa J. 2006. Five oximes (K-27, K-33, K-48, BI-6 and methoxime) in comparison with pralidoxime: in vitro reactivation of red blood cell acetylcholinesterase inhibited by paraoxon. J. Appl. Toxicol. 26: 64-71.
20. Petroianu GA, Missler A, Zuleger K, Thyes C, Ewald V, Maleck WH. 2004. Enzyme reactivator treatment in organophosphate exposure: the clinical relevance of thiocholine-esteratic activity of pralidoxime. J. Appl. Toxicol. 24: 429-435.
21. Petroianu G, Toomes LM, Petroianu A, Bergeler W, Rüfer R. 1998. Control of blood pressure, heart rate and haematocrit during high-dose intravenous paraoxon exposure in mini pigs. J. Appl. Toxicol. 18: 293-298.
22. van Helden HP, Busker RW, Melchers BPC, Bruijnzeel PLB. 1996. Pharmacological effects of oximes: how relevant are they? Arch. Toxicol. 70: 779-786.
23. van Kampen EJ, Zijlstra WG. 1961. Standardization of hemoglobinometry II. The hemoglobincyanide method. Clin. Chim. Acta 6: 538-544.
24. Wilson IB, Ginsburg S. 1955. A powerful reactivator of alkylphosphate. Biochim. Biophys. Acta 18: 168-170.
25. Worek F, Mast U, Kiderlen D, Diepold C, Eyer P. 1999. Improved determination of acetylcholinesterase activity in human whole blood. Clin. Chim. Acta 288: 73-90.
26. Zoch E. 1971. Die Wirkung organischer Phosphorsäureester bzw. Phosphorsäureester auf versch. Enzyme. Arzneimittelforschung. 21: 181-187.